CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Cardinal Health Inc. recalls Enoxaparin Sodium Injection

Read the official FDA notice

Published
3 Sept 2025
Units affected
10 bags
Agency
FDA
Country
United States

The hazard

Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bags of 5 prefilled syringes, Rx Only, Dist. by: Sandoz Inc., Princeton, NJ 08540, Outer package - NDC 55154-3543-5, Inner label - NDC 0781-3238-01

Brand / company
Cardinal Health Inc.
Codes / lots
Outer package - NDC 55154-3543-5, Lot SAD08033AA Inner label - NDC 0781-3238-01, Lot SAF13211A
Distribution
KS
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 3 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.